Safety End Points
Veena Hoffman
Optum, Boston, MA, USA, United States
Jesper Hallas, MD DMSc
Professor
University of Southern Denmark, Odense, Denmark
Odense C, Syddanmark, Denmark
Marie Linder
Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden, Sweden
Andrea V. Margulis, FISPE
RTI Health Solutions
BARCELONA, Barcelona, Spain
Brandon T. Suehs
Humana Healthcare Research, Louisville, KY, USA, United States
Alejandro Arana
RTI Health Solutions, Barcelona, Spain, Spain
Cheryl Enger
Optum, Boston, MA, USA, United States
Libby Horter
Humana Healthcare Research, Louisville, KY, USA, United States
Ingvild Odsbu
Researcher
Karolinska Institutet
Oslo, Oslo, Norway
Morten Olesen
University of Southern Denmark, Odense, Denmark, Denmark
Susana Perez-Gutthann
RTI Health Solutions, Barcelona, Spain, Spain
Yihua Xu
Humana Healthcare Research, Louisville, KY, USA, United States
Nina S. Kristiansen
University of Southern Denmark, Odense, Denmark, Denmark
Kwame Appenteng
Astellas Pharma US, Chicago, IL, USA, United States
Stefan de Vogel
Astellas Pharma Europe B.V., Leiden, the Netherlands, Netherlands
John D. Seeger, PharmD, FISPE
Optum Epidemiology
Boston, Massachusetts, United States